0001140361-21-021503.txt : 20210617 0001140361-21-021503.hdr.sgml : 20210617 20210617192607 ACCESSION NUMBER: 0001140361-21-021503 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210615 FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEDU-ADDO FRANK CENTRAL INDEX KEY: 0001770756 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37568 FILM NUMBER: 211026532 MAIL ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 400 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDS Biotechnology Corp CENTRAL INDEX KEY: 0001472091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264231384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25B VREELAND ROAD STREET 2: SUITE 300 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: 800-208-3343 MAIL ADDRESS: STREET 1: 25B VREELAND ROAD STREET 2: SUITE 300 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 FORMER COMPANY: FORMER CONFORMED NAME: Edge Therapeutics, Inc. DATE OF NAME CHANGE: 20090911 4 1 form4.xml FORM 4 X0306 4 2021-06-15 0001472091 PDS Biotechnology Corp PDSB 0001770756 BEDU-ADDO FRANK C/O PDS BIOTECHNOLOGY CORPORATION 25B VREELAND ROAD FLORHAM PARK NJ 07932 true true President/CEO Common Stock 2021-06-15 4 M 0 53174 6.57 A 673681 D Common Stock 2021-06-15 4 F 0 27166 12.86 D 646515 D Stock Option (Right to Buy) 6.57 2021-06-15 4 M 0 53174 0 D 2021-07-27 Common Stock 53174 0 D On June 15, 2021, Mr. Bedu-Addo made a net exercise of 53,174 stock options, resulting in his acquisition of 26,008 common shares of the Issuer. The transaction was made pursuant to an exception to a lock-up agreement between Mr. Bedu Addo and Cantor Fitzgerald & Co.in connection with a public offering of common shares by the Issuer which closed on June 17, 2021. The Stock Option is fully vested in accordance with its terms. /s/ Frank Bedu-Addo 2021-06-17